Delhi HC extends stay on ban of some drugs till Mar 28

Several other pharma companies, which also filed appeals against the Centre’s notification, were not granted a similar relief but have been given “assurance” that no coercive action will be taken against them till the next date of hearing.

By: Express News Service | New Delhi | Updated: March 22, 2016 3:26 am
delhi high court, drugs ban, ban on drugs, health ministry, banned medicines, banned drugs in india, india banned medicines, banned drugs combinations, india ban drug combination, list of banned medicines in india, india news, health news, latest news The health department prohibited the manufacture and sale of 344 fixed-dose combination drugs this month, citing experts as saying there was no medical justification to administer them.

The Delhi High Court on Monday extended its interim order lifting ban on fixed dose combination (FDC) medicines of some pharmaceutical companies, which had got relief last week, till March 28.

Several other pharma companies, which also filed appeals against the Centre’s notification, were not granted a similar relief but have been given “assurance” that no coercive action will be taken against them till the next date of hearing.

Share This Article
Share
Related Article

In an affidavit, the government said that lifting the ban would be “against public interest and patient safety”. It claimed that the pharma companies were interested only in profit.

As of Monday, 112 petitions had been filed before the Delhi HC challenging the Centre’s March 10 notification banning more than 300 FDC drugs. The companies claim that the notification was issued without following the due process of issuing them a show-cause notice or hearing them.

The court had last week stayed operation of the Centre’s ban on some FDC drugs of 30 pharma companies. ENS

For all the latest India News, download Indian Express App

    Live Cricket Scores & Results
    Express Adda